Effect of simvastatin treatment on plasma apolipoproteins and hepatic apolipoprotein mRNA levels in the genetically hypercholesterolemic rat (RICO)

This publication has 22 references indexed in Scilit:

• Effect of a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor on triglyceride kinetics in chronically streptozotocin-diabetic rats
  Metabolism, 1993
• The discovery and development of HMG-CoA reductase inhibitors.
  Journal of Lipid Research, 1992
• A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition
  Metabolism, 1992
• Effect of simvastatin on receptor mediated metabolism of low density lipoprotein in guinea pigs
  Atherosclerosis, 1991
• Selective inhibition of cholesterol synthesis in liver versus extrahepatic tissues by HMG-CoA reductase inhibitors.
  Journal of Lipid Research, 1990
• Effect of Pravastatin sodium, a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on very-low-density lipoprotein composition and kinetics in hyperlipidemia associated with experimental nephrosis
  Metabolism, 1990
• Effect of simvastatin on receptor-dependent low density lipoprotein catabolism in normocholesterolemic human volunteers
  Atherosclerosis, 1989
• Induction of mRNA for low-density lipoprotein receptors in heterozygous Watanabe heritable hyperlipidemic rabbits treated with CS-514 (Pravastatin) and cholestyramine.
  Circulation, 1989
• Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo
  Biochemical and Biophysical Research Communications, 1989
• Effects of ML-236B on cholesterol metabolism in mice and rats: Lack of hypocholesterolemic activity in normal animals
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1979